(CBAY) Cymabay Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Cymabay Therapeutics | (CBAY) share price targets
Complete technical analysis of Cymabay Therapeutics (CBAY) by charts plus indicators, forecast predictions and share price targets for Cymabay Therapeutics (CBAY)
Cymabay Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-08 View latest technical analysis
10 day averaged volume of Cymabay Therapeutics is 3090100
| Date | Daily Closing Price | Open | High | Low | Volume |
| 08 Fri Mar 2024 | 32.31 | 32.30 | 32.33 | 32.28 | 0.573 times |
| 07 Thu Mar 2024 | 32.30 | 32.28 | 32.30 | 32.27 | 0.378 times |
| 06 Wed Mar 2024 | 32.29 | 32.25 | 32.30 | 32.25 | 0.452 times |
| 05 Tue Mar 2024 | 32.24 | 32.21 | 32.27 | 32.19 | 0.738 times |
| 04 Mon Mar 2024 | 32.18 | 32.24 | 32.30 | 32.16 | 0.697 times |
| 01 Fri Mar 2024 | 32.23 | 32.23 | 32.35 | 32.19 | 1.132 times |
| 29 Thu Feb 2024 | 32.19 | 32.28 | 32.30 | 32.17 | 2.561 times |
| 28 Wed Feb 2024 | 32.27 | 32.32 | 32.33 | 32.26 | 1.128 times |
| 27 Tue Feb 2024 | 32.32 | 32.26 | 32.33 | 32.24 | 0.919 times |
| 26 Mon Feb 2024 | 32.28 | 32.23 | 32.31 | 32.21 | 1.056 times |
My analysis of stock is bullish for shortterm, and stock might move up till 33.3 or till 35. Use a stoploss of 31.9 and if this stock hits its stoploss, then it can fall down till 30.47
Share price targets for Cymabay Therapeutics (CBAY)
| Target Type | Value |
| Downside Target | 14.20 |
| Downside Target | 18.27 |
| Downside Target | 19.79 |
| Downside Target | 22.11 |
| Downside Target | 23.22 |
| Downside Target | 25.33 |
| Downside Target | 26.35 |
| Downside Target | 31.92 |
| Downside Target | 32.24 |
| Downside Target | 32.26 |
| Upside Target | 32.33 |
| Upside Target | 32.35 |
Intraday share price targets for Cymabay Therapeutics (CBAY)
| Target Type | Value |
| Downside Intraday Target | 32.2 |
| Downside Intraday Target | 32.1 |
| Upside Intraday Target | 32.37 |
| Upside Intraday Target | 32.44 |
| Downside Intraday Target | 32.27 |
Weekly technical analysis of Cymabay Therapeutics (CBAY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 08 Fri Mar 2024 | 32.31 | 32.24 | 32.33 | 32.16 | 0.417 times |
| 01 Fri Mar 2024 | 32.23 | 32.23 | 32.35 | 32.17 | 1.787 times |
| 23 Fri Feb 2024 | 32.23 | 32.14 | 32.26 | 32.14 | 0.099 times |
| 16 Fri Feb 2024 | 32.18 | 31.93 | 32.24 | 31.92 | 20.154 times |
| 09 Fri Feb 2024 | 25.69 | 23.54 | 26.35 | 23.24 | 1.107 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Cymabay Therapeutics (CBAY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 08 Fri Mar 2024 | 32.31 | 32.23 | 32.35 | 32.16 | 0.079 times |
| 29 Thu Feb 2024 | 32.19 | 23.69 | 32.33 | 23.22 | 5.66 times |
| 31 Wed Jan 2024 | 23.51 | 23.45 | 25.37 | 22.11 | 0.626 times |
| 29 Fri Dec 2023 | 23.62 | 19.03 | 25.33 | 18.27 | 1.02 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Cymabay Therapeutics (CBAY)
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cymabay Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Cymabay Therapeutics in short term but the sell signal is initial and weak.
Cymabay Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cymabay Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Cymabay Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.25 and Cymabay Therapeutics (CBAY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cymabay Therapeutics (CBAY) stock. Volume based technical analysis of Cymabay Therapeutics (CBAY) stock is negative.
Cymabay Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Cymabay Therapeutics ( (CBAY) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Cymabay Therapeutics stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Cymabay Therapeutics in short term but the sell signal is initial and weak.
Cymabay Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Cymabay Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Cymabay Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 32.25 and Cymabay Therapeutics (CBAY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Cymabay Therapeutics (CBAY) stock. Volume based technical analysis of Cymabay Therapeutics (CBAY) stock is negative.
Cymabay Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.